Blueprint Medicines Debt to Equity Ratio Analysis

Blueprint Medicines Corp (BPMC)

94.15 -2.47 (-2.56%) USD | NASDAQ | Nov 22, 16:00

94.20 +0.05 (+0.05%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2015. Upgrade now.

Date	Value
September 30, 2024	1.234
June 30, 2024	1.208
March 31, 2024	0.7705
December 31, 2023	1.828
September 30, 2023	1.176
June 30, 2023	0.45
March 31, 2023	0.3367
December 31, 2022	0.2702
September 30, 2022	0.2161
June 30, 2022	0.00
March 31, 2022	0.00
December 31, 2021	0.00
September 30, 2021	0.00
June 30, 2021	0.00
March 31, 2021	0.00
December 31, 2020	0.00
September 30, 2020	0.00
June 30, 2020	0.00
March 31, 2020	0.00
December 31, 2019	0.00

Date	Value
September 30, 2019	0.00
June 30, 2019	0.00
March 31, 2019	0.00
December 31, 2018	0.00
September 30, 2018	0.0006
June 30, 2018	0.0013
March 31, 2018	0.0019
December 31, 2017	0.0024
September 30, 2017	0.0061
June 30, 2017	0.0071
March 31, 2017	0.0172
December 31, 2016	0.0191
September 30, 2016	0.05
June 30, 2016	0.0507
March 31, 2016	0.0503
December 31, 2015	0.051
September 30, 2015	0.0498
June 30, 2015	0.0487
March 31, 2015	0.35

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

Dec 2019

1.828

Maximum

Dec 2023

0.3746

Average

Median